Archives

Ceretas Limited (ASX: CTS), a medical technology company developing a portable, non-invasive therapeutic ultrasound platform for treating Alzheimer's disease and other neurodegenerative conditions, was admitted to the Official List of ASX on Tuesday, 21 July 2026. The company commenced quotation on Thursday, 23 July 2026, following a capital raise of $8 million through the issue of 32 million fully-paid ordinary shares at $0.25 per share. The listing provides Ceretas with capital to advance its therapeutic ultrasound technology platform towards clinical commercialisation.

• July 21, 2026 04:46 PM AEST
• Sonal Goyal

Australia's headline benchmark has pressed against overhead resistance after tracing a rounded base, with softening momentum and clear support shelves leaving the chart poised between a confirmed breakout and a pullback.

• July 21, 2026 04:46 PM AEST
• Sam

The Australian technology gauge has curled higher, reclaiming its rising average and printing higher lows as momentum turns supportive, leaving a nearby resistance zone as the decisive test for a breakout.

• July 21, 2026 04:46 PM AEST
• Sam

Australia's heavyweight mining charts have diverged, pulling the broad benchmark in competing directions as a leading resource producer tests a long-running ascending trendline that could steady or unsettle the market.

• July 21, 2026 04:46 PM AEST
• Sam

Lynas Rare Earths keeps surfacing on value screens, trading at a meaningful discount to a widely cited estimate of intrinsic worth as demand for magnet metals firms. The gap rests on punchy growth forecasts and a strategic supply story that a standard model struggles to capture. Tickers used:ASX:LYC Alternate headline 1:Is This ASX Rare Earths Name Trading Below Its Worth? Alternate headline 2:Magnet-Metal Demand Puts an ASX Producer on Value Radars

• July 21, 2026 04:44 PM AEST
• Sam

CurveBeam AI Limited (CVB) will convene a general meeting on 21 August 2026 to seek shareholder approval for a $5 million capital raise through the placement of shares to multiple parties, including strategic investor Intellivision Holdings Pte. Ltd and related parties. The company, which develops AI-powered musculoskeletal imaging technology, requires shareholder approval across four interconditional resolutions to proceed with the placement. Failure to pass all resolutions will prevent the capital raise and may impact the company's ability to meet financial obligations due in October 2027.

• July 21, 2026 04:43 PM AEST
• Manish Choudhary

Mining services contractors are turning up on value screens, with NRW Holdings trading at a notable discount to a modelled estimate of fair value as firm order books meet brisk forecast growth. Backlog quality and contract margins are the levers that will decide the case. Tickers used:ASX:NWH, ASX:LYL Alternate headline 1:Are ASX Mining Contractors the Market's Value Blind Spot? Alternate headline 2:Full Order Books Put ASX Services Names on Value Screens

• July 21, 2026 04:43 PM AEST
• Sam

ALS Limited, a global testing and inspection group, has surfaced on value screens trading below a modelled estimate of fair value after a strong run in earnings. The offset sits in a heavier debt load, the counterweight the market must weigh against the discount. Tickers used:ASX:ALQ Alternate headline 1:Can This ASX Testing Group's Growth Close Its Discount? Alternate headline 2:Steady Fees Put an ASX Services Name on Value Screens

• July 21, 2026 04:43 PM AEST
• Sam

NeuroTech International Limited (NTI) has completed the conversion of 5 million performance rights into ordinary fully paid shares, expanding the company's issued capital on the ASX. The conversion follows shareholder approval granted at a general meeting in August 2024 and was finalised on 21 July 2026. The move increases NeuroTech's total quoted ordinary share capital to approximately 1.32 billion shares, with the conversion valued at an estimated AUD $0.018 per share based on the closing price as at 20 July 2026.

• July 21, 2026 04:40 PM AEST
• Aditi Sarkar

Citigroup Global Markets Australia has suspended trading in three CitiFirst MINIs following stop loss trigger events on 21 July 2026. The suspended products track National Australia Bank Limited, Liontown Resources Limited, and Helia Group Limited. Holders of these structured products will have a temporary trading window to sell their positions to Citigroup at the stop loss amount, with automatic settlement within 10 business days if no sale occurs during that period.

• July 21, 2026 04:40 PM AEST
• Aditi Sarkar